Your Health, We Care
Used to treat adult patients with moderate to severe rheumatoid arthritis (RA) who have insufficient or intolerant response to one or more disease modifying antirheumatic drugs (DMARD). In terms of medication, filgotinib can be used as a monotherapy or in combination with methotrexate (MTX).
from FDA，2023.07
Used for relapsed/refractory mantle cell lymphoma and other B-cell malignancies.【more】
Release date：2026-01-05Recommended：5
Adult patients with moderate to severe rheumatoid arthritis (RA) who have insuff···【more】
Release date：2026-01-05Recommended：5
LuciusVersionofFilgotinib:DosageandAdministration,Indications,PrecautionsIndicat···【more】
Release date：2025-12-10Recommended：54
